60 related articles for article (PubMed ID: 24795022)
1. Angiogenesis-related gene mutations drive a subset of angiosarcomas.
Cancer Discov; 2014 May; 4(5):OF18. PubMed ID: 24795022
[TBL] [Abstract][Full Text] [Related]
2. Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
Behjati S; Tarpey PS; Sheldon H; Martincorena I; Van Loo P; Gundem G; Wedge DC; Ramakrishna M; Cooke SL; Pillay N; Vollan HKM; Papaemmanuil E; Koss H; Bunney TD; Hardy C; Joseph OR; Martin S; Mudie L; Butler A; Teague JW; Patil M; Steers G; Cao Y; Gumbs C; Ingram D; Lazar AJ; Little L; Mahadeshwar H; Protopopov A; Al Sannaa GA; Seth S; Song X; Tang J; Zhang J; Ravi V; Torres KE; Khatri B; Halai D; Roxanis I; Baumhoer D; Tirabosco R; Amary MF; Boshoff C; McDermott U; Katan M; Stratton MR; Futreal PA; Flanagan AM; Harris A; Campbell PJ
Nat Genet; 2014 Apr; 46(4):376-379. PubMed ID: 24633157
[TBL] [Abstract][Full Text] [Related]
3. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
[TBL] [Abstract][Full Text] [Related]
4. A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells.
Kunze K; Spieker T; Gamerdinger U; Nau K; Berger J; Dreyer T; Sindermann JR; Hoffmeier A; Gattenlöhner S; Bräuninger A
Cancer Res; 2014 Nov; 74(21):6173-83. PubMed ID: 25252913
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.
Prenen H; Smeets D; Mazzone M; Lambrechts D; Sagaert X; Sciot R; Debiec-Rychter M
Oncotarget; 2015 Nov; 6(34):36418-25. PubMed ID: 26474454
[TBL] [Abstract][Full Text] [Related]
6. Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.
Murali R; Chandramohan R; Möller I; Scholz SL; Berger M; Huberman K; Viale A; Pirun M; Socci ND; Bouvier N; Bauer S; Artl M; Schilling B; Schimming T; Sucker A; Schwindenhammer B; Grabellus F; Speicher MR; Schaller J; Hillen U; Schadendorf D; Mentzel T; Cheng DT; Wiesner T; Griewank KG
Oncotarget; 2015 Nov; 6(34):36041-52. PubMed ID: 26440310
[TBL] [Abstract][Full Text] [Related]
7. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit.
Miettinen M; Sarlomo-Rikala M; Lasota J
Mod Pathol; 2000 May; 13(5):536-41. PubMed ID: 10824925
[TBL] [Abstract][Full Text] [Related]
8. Comparative genomic hybridization in four angiosarcomas of the female breast.
Baumhoer D; Gunawan B; Becker H; Füzesi L
Gynecol Oncol; 2005 May; 97(2):348-52. PubMed ID: 15863129
[TBL] [Abstract][Full Text] [Related]
9. Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
Liau JY; Tsai JH; Yang CY; Lee JC; Liang CW; Hsu HH; Jeng YM
Hum Pathol; 2015 Sep; 46(9):1360-6. PubMed ID: 26190196
[TBL] [Abstract][Full Text] [Related]
10. Connexin 37 mutations in rat hepatic angiosarcomas induced by vinyl chloride.
Saito T; Barbin A; Omori Y; Yamasaki H
Cancer Res; 1997 Feb; 57(3):375-7. PubMed ID: 9012458
[TBL] [Abstract][Full Text] [Related]
11. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2.
Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP
Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
[TBL] [Abstract][Full Text] [Related]
13. Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast skin following radiotherapy.
Santi R; Cetica V; Franchi A; Pepi M; Cesinaro AM; Miracco C; Paglierani M; De Giorgi V; Delfino C; Difonzo EM; Pimpinelli N; Bianchi S; Sardi I; Santucci M; Massi D
Histopathology; 2011 Feb; 58(3):455-66. PubMed ID: 21323968
[TBL] [Abstract][Full Text] [Related]
14. PTPRJ: a novel inherited thrombocytopenia gene.
Wen R; Wang D
Blood; 2019 Mar; 133(12):1272-1274. PubMed ID: 30898775
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of K-ras-2 in liver angiosarcoma and adjacent nonneoplastic liver tissue from patients occupationally exposed to vinyl chloride.
Weihrauch M; Bader M; Lehnert G; Koch B; Wittekind C; Wrbitzky R; Tannapfel A
Environ Mol Mutagen; 2002; 40(1):36-40. PubMed ID: 12211074
[TBL] [Abstract][Full Text] [Related]
16. Nonsense mutation of the stereociliar membrane protein gene PTPRQ in human hearing loss DFNB84.
Shahin H; Rahil M; Abu Rayan A; Avraham KB; King MC; Kanaan M; Walsh T
J Med Genet; 2010 Sep; 47(9):643-5. PubMed ID: 20472657
[TBL] [Abstract][Full Text] [Related]
17. Angiosarcoma.
Young RJ; Brown NJ; Reed MW; Hughes D; Woll PJ
Lancet Oncol; 2010 Oct; 11(10):983-91. PubMed ID: 20537949
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic analysis of a primary bone angiosarcoma.
Dunlap JB; Magenis RE; Davis C; Himoe E; Mansoor A
Cancer Genet Cytogenet; 2009 Oct; 194(1):1-3. PubMed ID: 19737647
[TBL] [Abstract][Full Text] [Related]
19. Mutational status of K-ras and TP53 genes in primary sarcomas of the heart.
Garcia JM; Gonzalez R; Silva JM; Dominguez G; Vegazo IS; Gamallo C; Provencio M; España P; Bonilla F
Br J Cancer; 2000 Mar; 82(6):1183-5. PubMed ID: 10735503
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies.
Duddy SK; Gorospe SM; Bleavins MR; de la Iglesia FA
Toxicol Appl Pharmacol; 1999 Oct; 160(2):133-40. PubMed ID: 10527912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
